A compound-target pairs dataset: differences between drugs, clinical candidates and other bioactive compounds
Anna Lina Heinzke(European Bioinformatics Institute), Andrew R. Leach(LifeArc), Axel Pahl(Max Planck Institute of Molecular Physiology), Robert J. Young(Age UK), Barbara Zdrazil(European Bioinformatics Institute), Herbert Waldmann(Max Planck Society), Paul D. Leeson(RED Consulting (Norway))
Cited by 3
Related Papers
Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. Cohen
|Journal of Molecular Biology|1997|6.7k
ChEMBL: towards direct deposition of bioassay data
|Nucleic Acids Research|2018|2.5k
The ChEMBL database in 2017
|Nucleic Acids Research|2016|2.4k
Molecular Modelling: Principles and Applications
|Unknown|1996|1.9k
An analysis of the attrition of drug candidates from four major pharmaceutical companies
|Nature Reviews Drug Discovery|2015|1.4k